Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Cencora, Inc.COR · Entity 2994 | Director | October 01, 2026 | October 05, 2026 |
| RYDER SYSTEM INCR · Entity 3563 | Director · Chair and CEO | February 24, 2026 | February 26, 2026 |
| TEXAS INSTRUMENTS INCTXN · Entity 2834 | Director | January 29, 2026 | February 02, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Cencora, Inc.
Report date October 01, 2026 · Filed October 05, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 275 |
Reported balance
After 2026-10-01 transaction · row 2
1 source rowRow 2 · 2026-10-01 · Grant · Acquired 275 · Balance 275 F2: Grant of restricted stock units received for no consideration and vests 100% on the first anniversary of the date of the grant. |
| Common StockSEC Table I · non-derivative | IndirectBy revocable trust | 197 |
Reported balance
Holding disclosure · report date 2026-10-01 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 197 F1: These shares are held in trust on behalf of the reporting person. The reporting person disclaims beneficial ownership of the shares held by the trust except to the extent of the reporting person's pecuniary interest therein. |
Filing footnotes · ownership attribution and instrument terms
F1: These shares are held in trust on behalf of the reporting person. The reporting person disclaims beneficial ownership of the shares held by the trust except to the extent of the reporting person's pecuniary interest therein.
F2: Grant of restricted stock units received for no consideration and vests 100% on the first anniversary of the date of the grant.
RYDER SYSTEM INC
Report date February 24, 2026 · Filed February 26, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| common stockSEC Table I · non-derivative | Direct | 40,828 |
Ending reported balance
After 2026-02-24 transaction · row 5
5 source rows · reconciled sequenceRow 1 · 2026-02-24 · Exercise / conversion · Acquired 104,390 · Balance 145,218 Row 2 · 2026-02-24 · Tax withholding · Disposed 62,611 · Balance 82,607 Row 3 · 2026-02-24 · Sale · Disposed 40,841 · Balance 41,766 F1: This reflects the weighted average price at which the shares were sold. The sale price ranged from $222.78 to $223.76. The reporting person will provide, upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each price. Row 4 · 2026-02-24 · Sale · Disposed 676 · Balance 41,090 F2: This reflects the weighted average price at which the shares were sold. The sale price ranged from $223.81 to $224.07. The reporting person will provide, upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each price. Row 5 · 2026-02-24 · Sale · Disposed 262 · Balance 40,828 F3: This reflects the weighted average price at which the shares were sold. The sale price ranged from $225.10 to $225.13. The reporting person will provide, upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each price. |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $76.49 · Expires 2027-02-09 | Direct | 0 |
Reported balance
After 2026-02-24 transaction · row 9
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 9 · 2026-02-24 · Exercise / conversion · Disposed 104,390 · Balance 0 F4: The stock options vest in three equal installments on February 10, 2018, February 10, 2019 and February 10, 2020. |
| common stockSEC Table I · non-derivative | IndirectThe Robert E. Sanchez Revocable Trust | 492,982 |
Reported balance
Holding disclosure · report date 2026-02-24 · row 6
Holding and transaction disclosures are not merged.
1 source rowRow 6 · Balance 492,982 |
| common stockSEC Table I · non-derivative | IndirectBy Ryder Employee Savings Plan | 28,444 |
Reported balance
Holding disclosure · report date 2026-02-24 · row 7
Holding and transaction disclosures are not merged.
1 source rowRow 7 · Balance 28,444 |
| common stockSEC Table I · non-derivative | IndirectBy Ryder Deferred Compensation Plan | 3,710 |
Reported balance
Holding disclosure · report date 2026-02-24 · row 8
Holding and transaction disclosures are not merged.
1 source rowRow 8 · Balance 3,710 |
Filing footnotes · ownership attribution and instrument terms
F1: This reflects the weighted average price at which the shares were sold. The sale price ranged from $222.78 to $223.76. The reporting person will provide, upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each price.
F2: This reflects the weighted average price at which the shares were sold. The sale price ranged from $223.81 to $224.07. The reporting person will provide, upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each price.
F3: This reflects the weighted average price at which the shares were sold. The sale price ranged from $225.10 to $225.13. The reporting person will provide, upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each price.
F4: The stock options vest in three equal installments on February 10, 2018, February 10, 2019 and February 10, 2020.
TEXAS INSTRUMENTS INC
Report date January 29, 2026 · Filed February 02, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 21,600 |
Reported balance
After 2026-01-29 transaction · row 1
1 source rowRow 1 · 2026-01-29 · Grant · Acquired 525 · Balance 21,600 F1: Award of restricted stock units granted under the Texas Instruments 2018 Director Compensation Plan. |
| NQ Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $218.97 · Expires 2036-01-29 | Direct | 1,860 |
Reported balance
After 2026-01-29 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-01-29 · Grant · Acquired 1,860 · Balance 1,860 F2: The stock option becomes exercisable in four equal installments beginning on January 29, 2027. |
Filing footnotes · ownership attribution and instrument terms
F1: Award of restricted stock units granted under the Texas Instruments 2018 Director Compensation Plan.
F2: The stock option becomes exercisable in four equal installments beginning on January 29, 2027.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 17, 2014 Filed Jan 17, 2014 23:41 UTC | TEXAS INSTRUMENTS INC TXN · Entity 2834 | GrantStock Units · Derivative | 153.72 | $43.37 Strike: $1.00 | $6,666.84 |
DisclosureSEC source: 0001127602-14-002306 · form4.xml · derivative · entry 2 SANCHEZ ROBERT E · CIK 0001216931 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 153.72 Underlying: Common Stock · 153.72 shares Expires not disclosed F1 · derivative.exercise_price: Security converts to common stock on a one-for-one basis. F2 · derivative.exercise_date: Stock units credited under the Texas Instruments 2009 Director Compensation Plan, to be settled in common stock of the Issuer following the reporting person's termination of service as a director of the Issuer. End-of-period holdings include stock units acquired pursuant to the dividend reinvestment provision of the Plan. F2 · derivative.expiration_date: Stock units credited under the Texas Instruments 2009 Director Compensation Plan, to be settled in common stock of the Issuer following the reporting person's termination of service as a director of the Issuer. End-of-period holdings include stock units acquired pursuant to the dividend reinvestment provision of the Plan. F2 · balance_after: Stock units credited under the Texas Instruments 2009 Director Compensation Plan, to be settled in common stock of the Issuer following the reporting person's termination of service as a director of the Issuer. End-of-period holdings include stock units acquired pursuant to the dividend reinvestment provision of the Plan. Read SEC document |
| January 25, 2013 Filed Jan 29, 2013 21:49 UTC | TEXAS INSTRUMENTS INC TXN · Entity 2834 | GrantNQ Stock Option (Right to Buy) · Derivative | 14,749 | $0.00 Strike: $32.80 | $0.00 |
DisclosureSEC source: 0001127602-13-003039 · form4.xml · derivative · entry 2 SANCHEZ ROBERT E · CIK 0001216931 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,749 Underlying: Common Stock · 14,749 shares Expires 2023-01-25 F2 · derivative.exercise_date: The option becomes exercisable in four equal annual installments beginning on January 25, 2014. Read SEC document |
| January 25, 2013 Filed Jan 29, 2013 21:49 UTC | TEXAS INSTRUMENTS INC TXN · Entity 2834 | GrantCommon Stock | 3,048 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-13-003039 · form4.xml · nonDerivative · entry 1 SANCHEZ ROBERT E · CIK 0001216931 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,138 F1 · kind: Award of restricted stock units granted under the Texas Instruments 2009 Director Compensation Plan. Read SEC document |
| January 26, 2012 Filed Jan 31, 2012 00:13 UTC | TEXAS INSTRUMENTS INC TXN · Entity 2834 | GrantNQ Stock Option (Right to Buy) · Derivative | 12,156 | $0.00 Strike: $32.36 | $0.00 |
DisclosureSEC source: 0001127602-12-003080 · form4.xml · derivative · entry 2 SANCHEZ ROBERT E · CIK 0001216931 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,156 Underlying: Common Stock · 12,156 shares Expires 2022-01-26 F2 · derivative.exercise_date: The option becomes exercisable in four equal annual installments beginning on January 26, 2013. Read SEC document |
| January 26, 2012 Filed Jan 31, 2012 00:13 UTC | TEXAS INSTRUMENTS INC TXN · Entity 2834 | GrantCommon Stock | 3,090 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-12-003080 · form4.xml · nonDerivative · entry 1 SANCHEZ ROBERT E · CIK 0001216931 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,090 F1 · kind: Award of restricted stock units granted under the Texas Instruments 2009 Director Compensation Plan. Read SEC document |
| March 15, 2011 Filed Mar 16, 2011 21:03 UTC | TEXAS INSTRUMENTS INC TXN · Entity 2834 | GrantCommon Stock | 2,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-11-010375 · form4.xml · nonDerivative · entry 1 SANCHEZ ROBERT E · CIK 0001216931 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,000 F1 · kind: Award of restricted stock units granted under the Texas Instruments 2009 Director Compensation Plan. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.